Press Releases

BOSTON and LOS ANGELES, Dec. 20, 2019 /PRNewswire/ -- Comprehensive Autism Center (CAC), an autism services provider offering in-home and center-based ABA therapies, has been acquired by the Speech Pathology Group (SPG), a portfolio company of Ridgemont Equity Partners. CAC provides clinically proven, community-oriented, and out

NEW YORK, Dec. 20, 2019 /PRNewswire/ -- Lodo Therapeutics Corp., a biotechnology company applying its proprietary platform to reinvent environmentally-sourced, natural product drug discovery, today announced the appointment of Dale Pfost, PhD, as Chairman and Chief Executive Officer. Dr. Pfost has more than 25 years of experience as a

TARRYTOWN, N.Y., Dec. 20, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020.  The presentation is scheduled for 10:30 a.m. Pacific Time (

GUILFORD, Conn., Dec. 20, 2019 /PRNewswire/ -- Butterfly Network, Inc. announced today its new expanded compatibility of Butterfly iQ with 10 Samsung and Google devices and additional financing options from Affirm Inc., further democratizing medical imaging availability.

HOLON, Israel, Dec. 20, 2019 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ: ^NBI). Compugen's addition to the NBI will become effective prior to market open on

ISFIYA, Israel, Dec. 20, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestib

CHICAGO, Dec. 20, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that its board of directors has nominated Felicia Norwood to stand for election as a director at the company's Annual Meeting of Shareholders on February 25, 2020. Ms. Norwood's successful election would raise the number of director

STOCKHOLM, Dec. 20, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with a focus on Alzheimer's disease, announces that it has obtained the necessary approvals from the regulatory authorities and today initiates the first clinica

NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Dedicated to shaping the next frontier of surgery, Johnson & Johnsoni (NYSE: JNJ) today announced an agreement to acquire the remaining stake in Verb Surgical Inc. following a successful strategic collaboration with

Ortho Dermatologics Will Maintain Market Exclusivity for BRYHALI Lotion Until 2026¹ LAVAL, Quebec, Dec. 20, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, have ag